Paydirt
MI
Insider

Mohamed Khairie Issa

EVP, Head of US Oncology

Mohamed Khairie Issa (EVP, Head of US Oncology) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Incyte Corporation (INCY). The largest single filing was $1.2M of INCY (10,856 sh × $109.07, as filed), executed Jan 7.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Jul 16
Filed Jul 20

Median ADV $231.2M across their filed names

Open performance
Volume by month
$1.2M$592K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2026 · sells $1.2MJul 2026 · sells $126K
Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
INCY Incyte Corporation INCY · 0 buys · 2 sells 2 filings
Recent filings
INCYSALE Incyte Corporation View filing → $126K
1,093 sh × $115.01
Exec Jul 16
Filed Jul 20 · 4:09 PM ET
INCYSALE Incyte Corporation View filing → $1.2M
10,856 sh × $109.07
Exec Jan 7
Filed Jan 8 · 5:30 PM ET